Tirzepatide Outperforms Insulin Glargine in HbA1c and Weight Loss

SURPASS-4 is a randomized controlled trial of tirzepatide once a week vs. insulin glargine once a day in type 2 diabetes patients with high …

Read more at www.diabetesincontrol.com